Strengths of this study include sampling of cTnI from a large cohort of individuals with DM1, recruited from routine outpatient clinics across three different health regions, including annual review appointments offered to all individuals with DM1 known to their regional Clinical Genetics service. This evidence concerns the gene TNNI3 and myotonic dystrophy type 1.